Fore Research & Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-11,930	Closed	-$435K	–	97
2014 Q2	$435K	Buy	11,930 +1,930	+19%	+$70.4K	0.01%	45
2014 Q1	$458K	Sell	10,000 -13,468	-57%	-$617K	0.01%	54
2013 Q4	$913K	Buy	23,468 +3,468	+17%	+$135K	0.04%	34
2013 Q3	$906K	Buy	+20,000	New	+$906K	0.06%	36